| Serial Number | 99518921 |
| Word Mark | SELEXOR |
| Filing Date | Wednesday, November 26, 2025 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, April 21, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 12, 2026 |
| Goods and Services | Software as a service (SAAS) featuring software for designing gene therapies that restrict expression to specific cells through use of alternative splicing |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 26, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Aletira Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Baltimore, MD 21230 US |
| Event Date | Event Description |
| Wednesday, November 26, 2025 | NEW APPLICATION ENTERED |
| Wednesday, November 26, 2025 | APPLICATION FILING RECEIPT MAILED |
| Thursday, February 12, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 31, 2026 | ASSIGNED TO EXAMINER |
| Monday, April 13, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, April 13, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Monday, April 13, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, April 13, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Monday, April 13, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |